跳至主要内容
临床试验/NL-OMON27156
NL-OMON27156招募中不适用

CCT: Continuous Care Trial - a randomized controlled trial of continuous care during labor by a maternity care assistant in The Netherlands.

ZonMW0 个研究点目标入组 992 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
ZonMW
入组人数
992

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Planned vaginal birth
  • Women from 18 years or older
  • Pregnancy in third trimester
  • Living in the region of south Limburg

排除标准

  • Planned caesarean
  • Not able to read informed consent (knowledge of Dutch language)

研究者

发起方
ZonMW

相似试验

已完成
不适用
Continuing Care Project: A randomised controlled trial of a continuing care telephone intervention following residential substance dependence treatment.Substance dependenceMental Health - AddictionAlcohol dependence
ACTRN12618001231235Associate Professor Peter Kelly277
已完成
不适用
Study examining the effects of altering a diet's macronutrient composition on plasma ketone levels in women with gestational diabetes mellitusReproductive Health and Childbirth - Antenatal careReproductive Health and Childbirth - Fetal medicine and complications of pregnancyMetabolic and Endocrine - DiabetesGestational Diabetes Mellitus
ACTRN12616000018415The University of Sydney45
进行中(未招募)
不适用
et's Grow: Evaluating the efficacy of a mobile-web app on sedentary behaviour, physical activity and sleep in 2-year-old children.Sedentary behaviourPhysical inactivitySleepPublic Health - Health promotion/education
ACTRN12620001280998Deakin University1,367
已完成
不适用
A Randomised Controlled Trial (RCT) to evaluate the acceptability and cost-implications of Using Multimedia to Educate Patients with asthma on Inhaler Administration.Respiratory tract diseases: AsthmaRespiratoryAsthma
ISRCTN29905514Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)174
进行中(未招募)
1 期
Clinical trial to assess the efficacy of Plasma Rich in Growth Factors (PRGF®) in the treatment of vulvar lichen sclerosus atrophicusVulvar Lichen Sclerosus et atrophicus
EUCTR2021-006474-23-ESBTI I MAS D S.L.30